Grant: Undergraduate: Summer Studentship Award - Institute Community Support
McMaster University
$5,000.00
Examining the mechanism underlying statin-induced muscle pain.
EF 2016-17
Résumé
Despite the significant advances in medicine and healthcare that have been achieved in the past decades, cardiovascular disease (CVD) remains the most prominent cause of death worldwide. Many preventative treatments and drugs have been developed in an effort to control incidences of CVD. Perhaps the foremost of these pharmaceuticals is a class of cholesterol lowering drugs commonly referred to as statins. Statins are used to manage high cholesterol in individuals with or at risk for developing CVD and have been used with great efficacy. Statin-induced muscle pain (myalgia), is the most common statin-associated side effect and is the primary factor leading to statin treatment discontinuation. What causes these symptoms is unknown. In the proposed studies we will investigate potential mechanisms leading to muscle pain and identify potential therapeutics for the treatment of myalgia. Determining the mechanism of statin induced myalgia is crucial to the development of novel pharmaceuticals and/or combinatorial treatments which can manage hypocholesteremia in a safe, effective manner.
Programme
Undergraduate: Summer Studentship Award - Institute Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
364300
Name
Cao Andrew W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Summer Studentships in Musculoskeletal Health
Projecttitle
Examining the mechanism underlying statin-induced muscle pain.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Summer Studentship Award - Institute Community Support
Keyworddelim
Myalgia; Myopathy; Skeletal Muscle; Statin-Induced Myalgia; System Xc(-)
Abstract
Despite the significant advances in medicine and healthcare that have been achieved in the past decades, cardiovascular disease (CVD) remains the most prominent cause of death worldwide. Many preventative treatments and drugs have been developed in an effort to control incidences of CVD. Perhaps the foremost of these pharmaceuticals is a class of cholesterol lowering drugs commonly referred to as statins. Statins are used to manage high cholesterol in individuals with or at risk for developing CVD and have been used with great efficacy. Statin-induced muscle pain (myalgia), is the most common statin-associated side effect and is the primary factor leading to statin treatment discontinuation. What causes these symptoms is unknown. In the proposed studies we will investigate potential mechanisms leading to muscle pain and identify potential therapeutics for the treatment of myalgia. Determining the mechanism of statin induced myalgia is crucial to the development of novel pharmaceuticals and/or combinatorial treatments which can manage hypocholesteremia in a safe, effective manner.
Competitiondate
201701
Approvedterm2
0 yr 4 mths
Pinamesdelim
Cao, Andrew W
Approvedterm
0 an 4 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $5,000~ $0~